| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-19 ERVK-25 ERVK-24 ERVK-8 | 1.63e-09 | 37 | 280 | 9 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-19 ERVK-25 ERVK-24 ERVK-8 | 2.11e-09 | 38 | 280 | 9 | GO:0070001 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.16e-05 | 11 | 280 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.36e-05 | 38 | 280 | 6 | GO:0034061 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 SMARCAD1 ERVK-7 ERVK-10 RAD54B CHD6 POLD1 MSH2 BTAF1 INO80 APLF N4BP2 ERVK-8 POLI | 2.14e-05 | 262 | 280 | 14 | GO:0140097 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB2 ERVK-6 CRIM1 PDGFRA PDK1 LRRK2 STYK1 SCYL1 DAPK1 SNRK ERVK-7 PFKFB1 ERVK-10 MAST2 JAK3 MET FGFR4 WNK3 DPAGT1 POLD1 PARP2 PARP3 LRRK1 N4BP2 PRKAB1 ERVK-8 POLI UBA6 MUSK NLK | 2.34e-05 | 938 | 280 | 30 | GO:0016772 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.39e-05 | 14 | 280 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | TBP-class protein binding | 9.00e-05 | 33 | 280 | 5 | GO:0017025 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 DDX59 MARS1 SMARCAD1 ERVK-7 ERVK-10 CDKAL1 HENMT1 RAD54B CHD6 POLD1 PIWIL2 MSH2 BTAF1 INO80 ERI2 APLF N4BP2 RTCA ERVK-8 POLI PARN | 1.21e-04 | 645 | 280 | 22 | GO:0140640 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.58e-04 | 37 | 280 | 5 | GO:0140658 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX59 ABCA13 PSMC4 SMARCAD1 ABCA8 ATAD2B RAD54B CHD6 KIFC3 VCP MSH2 BTAF1 INO80 ENTPD2 UBA6 ABCB11 ATP1A3 ATP12A MYO15A ATP2B4 ATP4A | 1.66e-04 | 614 | 280 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX59 ABCA13 PSMC4 SMARCAD1 ABCA8 ATAD2B CHD6 VCP MSH2 BTAF1 INO80 ENTPD2 ABCB11 ATP1A3 ATP12A ATP2B4 ATP4A | 1.76e-04 | 441 | 280 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.88e-04 | 21 | 280 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 2.12e-04 | 145 | 280 | 9 | GO:0004713 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.97e-04 | 65 | 280 | 6 | GO:0004714 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 3.01e-04 | 152 | 280 | 9 | GO:0016779 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 3.04e-04 | 10 | 280 | 3 | GO:0005391 | |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 3.04e-04 | 10 | 280 | 3 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 4.14e-04 | 11 | 280 | 3 | GO:0008556 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 5.46e-04 | 12 | 280 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | P-type potassium:proton transporter activity | 5.82e-04 | 3 | 280 | 2 | GO:0008900 | |
| GeneOntologyMolecularFunction | NAD DNA ADP-ribosyltransferase activity | 5.82e-04 | 3 | 280 | 2 | GO:0140294 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 6.82e-04 | 29 | 280 | 4 | GO:0004629 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 8.72e-04 | 109 | 280 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 9.99e-04 | 32 | 280 | 4 | GO:0042288 | |
| GeneOntologyMolecularFunction | NAD+-protein-glutamate ADP-ribosyltransferase activity | 1.15e-03 | 4 | 280 | 2 | GO:0140807 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-19 ERVK-25 ERVK-24 USP1 CASP1 PDIA3 ERVK-8 ESPL1 CTSV SENP7 | 1.16e-03 | 430 | 280 | 15 | GO:0004175 |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.25e-03 | 85 | 280 | 6 | GO:0019199 | |
| GeneOntologyMolecularFunction | phosphatase binding | MAST2 ITPR1 JAK3 MET SMG7 SIGLEC10 LILRB5 VCP ANAPC4 IRS2 ATP2B4 | 1.31e-03 | 264 | 280 | 11 | GO:0019902 |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 1.33e-03 | 86 | 280 | 6 | GO:0004197 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.57e-03 | 36 | 280 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.57e-03 | 36 | 280 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | nuclease activity | ERVK-6 ERVK-7 ERVK-10 POLD1 PIWIL2 ERI2 APLF N4BP2 ERVK-8 PARN | 1.63e-03 | 231 | 280 | 10 | GO:0004518 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.74e-03 | 37 | 280 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme activity | 1.74e-03 | 37 | 280 | 4 | GO:0061631 | |
| GeneOntologyMolecularFunction | NAD+-protein-aspartate ADP-ribosyltransferase activity | 1.91e-03 | 5 | 280 | 2 | GO:0140806 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 2.03e-03 | 64 | 280 | 5 | GO:0140296 | |
| GeneOntologyMolecularFunction | protein kinase activity | EPHB2 CRIM1 PDGFRA PDK1 LRRK2 STYK1 SCYL1 DAPK1 SNRK MAST2 JAK3 MET FGFR4 WNK3 LRRK1 PRKAB1 MUSK NLK | 2.12e-03 | 600 | 280 | 18 | GO:0004672 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 1.37e-08 | 48 | 278 | 9 | GO:0000731 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 1.93e-05 | 85 | 278 | 8 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 1.93e-05 | 85 | 278 | 8 | GO:0000768 | |
| GeneOntologyBiologicalProcess | DNA integration | 2.10e-05 | 13 | 278 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | syncytium formation | 2.71e-05 | 89 | 278 | 8 | GO:0006949 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | ERVK-6 ERVK-7 ERVK-10 HROB FGFR4 USP1 VCP POLD1 PARP3 ERVK-8 POLI PARN | 4.28e-05 | 218 | 278 | 12 | GO:0071897 |
| GeneOntologyBiologicalProcess | sodium ion export across plasma membrane | 6.69e-05 | 17 | 278 | 4 | GO:0036376 | |
| GeneOntologyBiologicalProcess | regulation of production of molecular mediator of immune response | EPHB2 JAK3 SIGLEC10 PLCG2 NLRX1 PARP3 CASP1 MSH2 CR1 APLF P2RX7 IGHM | 7.48e-05 | 231 | 278 | 12 | GO:0002700 |
| Domain | HEAT_REPEAT | 7.68e-06 | 70 | 271 | 8 | PS50077 | |
| Domain | - | 1.17e-05 | 74 | 271 | 8 | 3.40.50.410 | |
| Domain | ROC | 1.20e-05 | 4 | 271 | 3 | PS51424 | |
| Domain | ROC_dom | 1.20e-05 | 4 | 271 | 3 | IPR020859 | |
| Domain | P-type_ATPase_IIC | 5.85e-05 | 6 | 271 | 3 | IPR005775 | |
| Domain | RNaseH-like_dom | 6.27e-05 | 69 | 271 | 7 | IPR012337 | |
| Domain | HEAT | 6.50e-05 | 48 | 271 | 6 | PF02985 | |
| Domain | ATPase_P-typ_TM_dom | 6.88e-05 | 16 | 271 | 4 | IPR023298 | |
| Domain | - | 6.88e-05 | 16 | 271 | 4 | 1.20.1110.10 | |
| Domain | Cation_ATPase_C | 8.89e-05 | 17 | 271 | 4 | PF00689 | |
| Domain | ATPase_P-typ_cation-transptr_C | 8.89e-05 | 17 | 271 | 4 | IPR006068 | |
| Domain | SNF2_N | 9.06e-05 | 32 | 271 | 5 | PF00176 | |
| Domain | SNF2_N | 9.06e-05 | 32 | 271 | 5 | IPR000330 | |
| Domain | VWF_A | 9.70e-05 | 99 | 271 | 8 | IPR002035 | |
| Domain | Cation_ATPase_N | 1.13e-04 | 18 | 271 | 4 | PF00690 | |
| Domain | Cation_ATPase_N | 1.13e-04 | 18 | 271 | 4 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.42e-04 | 19 | 271 | 4 | IPR004014 | |
| Domain | ARM-like | CAND1 CAND2 LRRK2 SCYL1 NCAPG NALF1 AP2A2 NBEAL2 ARMC8 TANGO6 BTAF1 IPO4 MEI1 | 1.68e-04 | 270 | 271 | 13 | IPR011989 |
| Domain | Leu-rich_rpt | LRRK2 CEP78 PHLPP1 LRRC41 NLRX1 LRRC40 SLITRK3 LRRK1 LRRC8D LRRCC1 LRRC61 ANP32D FBXL20 | 1.74e-04 | 271 | 271 | 13 | IPR001611 |
| Domain | VWFA | 1.88e-04 | 82 | 271 | 7 | PS50234 | |
| Domain | Laminin_G | 1.90e-04 | 58 | 271 | 6 | IPR001791 | |
| Domain | HEAT | 1.90e-04 | 58 | 271 | 6 | IPR000357 | |
| Domain | COR | 2.10e-04 | 2 | 271 | 2 | IPR032171 | |
| Domain | - | 2.10e-04 | 2 | 271 | 2 | 1.20.1420.10 | |
| Domain | VBS | 2.10e-04 | 2 | 271 | 2 | PF08913 | |
| Domain | Talin_cent | 2.10e-04 | 2 | 271 | 2 | IPR015224 | |
| Domain | Talin_middle | 2.10e-04 | 2 | 271 | 2 | PF09141 | |
| Domain | TIP120 | 2.10e-04 | 2 | 271 | 2 | PF08623 | |
| Domain | Tscrpt_rep_NocA-like | 2.10e-04 | 2 | 271 | 2 | IPR022129 | |
| Domain | nlz1 | 2.10e-04 | 2 | 271 | 2 | PF12402 | |
| Domain | Vinculin-bd_dom | 2.10e-04 | 2 | 271 | 2 | IPR015009 | |
| Domain | COR | 2.10e-04 | 2 | 271 | 2 | PF16095 | |
| Domain | TATA-bd_TIP120 | 2.10e-04 | 2 | 271 | 2 | IPR013932 | |
| Domain | VWA | 2.19e-04 | 84 | 271 | 7 | SM00327 | |
| Domain | - | ADCY10 DDX59 ABCA13 LRRK2 PSMC4 SMARCAD1 PFKFB1 ABCA8 ATAD2B RAD54B CHD6 GNAS VCP NOA1 MSH2 BTAF1 LRRK1 INO80 ARHGAP35 ARL3 DYNC2LI1 N4BP2 ABCB11 MYO15A | 2.37e-04 | 746 | 271 | 24 | 3.40.50.300 |
| Domain | P-loop_NTPase | ADCY10 DDX59 ABCA13 LRRK2 PSMC4 DAPK1 SMARCAD1 PFKFB1 ABCA8 ATAD2B RAD54B CHD6 KIFC3 GNAS VCP NOA1 MSH2 BTAF1 LRRK1 INO80 ARHGAP35 ARL3 DYNC2LI1 N4BP2 ABCB11 MYO15A | 2.76e-04 | 848 | 271 | 26 | IPR027417 |
| Domain | PSI | 4.24e-04 | 44 | 271 | 5 | IPR016201 | |
| Domain | UBQ-conjugating_AS | 4.31e-04 | 25 | 271 | 4 | IPR023313 | |
| Domain | ARM-type_fold | CAND1 GBF1 CAND2 LRRK2 SCYL1 ITPR1 NCAPG AP2A2 NBEAL2 ARMC8 TANGO6 BTAF1 IPO4 MEI1 | 4.59e-04 | 339 | 271 | 14 | IPR016024 |
| Domain | PSI | 5.22e-04 | 46 | 271 | 5 | SM00423 | |
| Domain | PROTEIN_KINASE_TYR | 5.30e-04 | 97 | 271 | 7 | PS00109 | |
| Domain | Tyr_kinase_AS | 5.30e-04 | 97 | 271 | 7 | IPR008266 | |
| Domain | PARP_reg | 6.23e-04 | 3 | 271 | 2 | PF02877 | |
| Domain | WGR | 6.23e-04 | 3 | 271 | 2 | PF05406 | |
| Domain | WGR | 6.23e-04 | 3 | 271 | 2 | SM00773 | |
| Domain | Talin-1 | 6.23e-04 | 3 | 271 | 2 | IPR015710 | |
| Domain | - | 6.23e-04 | 3 | 271 | 2 | 2.20.140.10 | |
| Domain | Ig-like_fold | EPHB2 PDGFRA PLXND1 MET PTPRB SIGLEC10 FGFR4 USH2A LILRB5 FLNB COL12A1 ABI3BP CD8A PLXNC1 TNN IGHM PRKAB1 CEACAM16 IGSF1 LY9 IL2RB MUSK | 6.60e-04 | 706 | 271 | 22 | IPR013783 |
| Domain | FERM_domain | 7.02e-04 | 49 | 271 | 5 | IPR000299 | |
| Domain | FERM_1 | 7.70e-04 | 50 | 271 | 5 | PS00660 | |
| Domain | FERM_2 | 7.70e-04 | 50 | 271 | 5 | PS00661 | |
| Domain | FERM_3 | 7.70e-04 | 50 | 271 | 5 | PS50057 | |
| Domain | Band_41_domain | 7.70e-04 | 50 | 271 | 5 | IPR019749 | |
| Domain | B41 | 7.70e-04 | 50 | 271 | 5 | SM00295 | |
| Domain | - | LRRK2 CEP78 PHLPP1 LRRC41 NLRX1 LRRC40 SLITRK3 LRRK1 LRRC8D LRRCC1 LRRC61 ANP32D FBXL20 | 8.71e-04 | 321 | 271 | 13 | 3.80.10.10 |
| Domain | IRS | 9.77e-04 | 14 | 271 | 3 | PF02174 | |
| Domain | IRS_PTB | 9.77e-04 | 14 | 271 | 3 | IPR002404 | |
| Domain | L_dom-like | LRRK2 CEP78 PHLPP1 LRRC41 NLRX1 LRRC40 SLITRK3 LRRK1 LRRC8D LRRCC1 LRRC61 ANP32D FBXL20 | 1.06e-03 | 328 | 271 | 13 | IPR032675 |
| Domain | PLCYc | 1.21e-03 | 15 | 271 | 3 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 1.21e-03 | 15 | 271 | 3 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 1.21e-03 | 15 | 271 | 3 | PS50008 | |
| Domain | EF-hand_like | 1.21e-03 | 15 | 271 | 3 | PF09279 | |
| Domain | PI-PLC-Y | 1.21e-03 | 15 | 271 | 3 | PF00387 | |
| Domain | PI-PLC_fam | 1.21e-03 | 15 | 271 | 3 | IPR001192 | |
| Domain | PLC_EF-hand-like | 1.21e-03 | 15 | 271 | 3 | IPR015359 | |
| Domain | PARP_ALPHA_HD | 1.23e-03 | 4 | 271 | 2 | PS51060 | |
| Domain | FERM_f0 | 1.23e-03 | 4 | 271 | 2 | PF16511 | |
| Domain | ILWEQ | 1.23e-03 | 4 | 271 | 2 | PD011820 | |
| Domain | Poly(ADP-ribose)pol_reg_dom | 1.23e-03 | 4 | 271 | 2 | IPR004102 | |
| Domain | - | 1.23e-03 | 4 | 271 | 2 | 1.20.5.630 | |
| Domain | I_LWEQ | 1.23e-03 | 4 | 271 | 2 | PF01608 | |
| Domain | I_LWEQ | 1.23e-03 | 4 | 271 | 2 | PS50945 | |
| Domain | FERM_f0 | 1.23e-03 | 4 | 271 | 2 | IPR032425 | |
| Domain | ILWEQ_dom | 1.23e-03 | 4 | 271 | 2 | IPR002558 | |
| Domain | ILWEQ | 1.23e-03 | 4 | 271 | 2 | SM00307 | |
| Domain | - | 1.23e-03 | 4 | 271 | 2 | 1.20.1410.10 | |
| Domain | - | 1.23e-03 | 4 | 271 | 2 | 1.20.142.10 | |
| Domain | VWA | 1.29e-03 | 56 | 271 | 5 | PF00092 | |
| Domain | LRR_1 | LRRK2 PHLPP1 LRRC41 LRRC40 SLITRK3 LRRK1 LRRC8D LRRCC1 LRRC61 FBXL20 | 1.40e-03 | 219 | 271 | 10 | PF00560 |
| Domain | VWF_type-D | 1.47e-03 | 16 | 271 | 3 | IPR001846 | |
| Domain | VWFD | 1.47e-03 | 16 | 271 | 3 | PS51233 | |
| Domain | VWD | 1.47e-03 | 16 | 271 | 3 | SM00216 | |
| Domain | VWD | 1.47e-03 | 16 | 271 | 3 | PF00094 | |
| Domain | - | 1.55e-03 | 222 | 271 | 10 | 1.25.10.10 | |
| Domain | ATPase_P-typ_cyto_domN | 1.59e-03 | 35 | 271 | 4 | IPR023299 | |
| Domain | - | EPHB2 PDGFRA PLXND1 MET PTPRB SIGLEC10 FGFR4 USH2A LILRB5 FLNB COL12A1 ABI3BP CD8A PLXNC1 TNN CEACAM16 IGSF1 LY9 IL2RB MUSK | 1.70e-03 | 663 | 271 | 20 | 2.60.40.10 |
| Domain | Tyr_kinase_cat_dom | 1.77e-03 | 88 | 271 | 6 | IPR020635 | |
| Domain | TyrKc | 1.77e-03 | 88 | 271 | 6 | SM00219 | |
| Domain | ATPase_P-typ_P_site | 1.77e-03 | 36 | 271 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 1.77e-03 | 36 | 271 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.77e-03 | 36 | 271 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.96e-03 | 37 | 271 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.96e-03 | 37 | 271 | 4 | PF00122 | |
| Domain | Groucho_enhance | 2.04e-03 | 5 | 271 | 2 | IPR009146 | |
| Domain | PLCXc | 2.10e-03 | 18 | 271 | 3 | SM00148 | |
| Domain | PI-PLC-X | 2.10e-03 | 18 | 271 | 3 | PF00388 | |
| Domain | LAM_G_DOMAIN | 2.17e-03 | 38 | 271 | 4 | PS50025 | |
| Domain | UQ_con | 2.39e-03 | 39 | 271 | 4 | PF00179 | |
| Domain | EGF | 2.44e-03 | 126 | 271 | 7 | PF00008 | |
| Domain | PIPLC_X_DOMAIN | 2.46e-03 | 19 | 271 | 3 | PS50007 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 4.42e-09 | 4 | 285 | 4 | 10469592 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | EPHB2 GBF1 ESR1 SCYL1 MAST2 PTPRB FAM186A CHD6 FGFR4 SLITRK3 GRIK4 BTAF1 LRRK1 MLXIPL EYS ERRFI1 MUSK UNC80 | 1.52e-08 | 420 | 285 | 18 | 28065597 |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.19e-08 | 5 | 285 | 4 | 12629516 | |
| Pubmed | 2.70e-08 | 12 | 285 | 5 | 14557543 | ||
| Pubmed | GBF1 SNRK DST SMG7 AP2A2 PHLPP1 ANKRD28 TLN2 CHD6 ARHGAP35 TLN1 DIP2C UNC80 | 5.21e-08 | 225 | 285 | 13 | 12168954 | |
| Pubmed | CAND2 PDK1 PSMC4 SMARCAD1 CDKAL1 ADD2 ITPR1 MET NAA35 NCAPG DLD ANKRD28 GNAS TMEM231 PLS3 VCP LRRC41 MAPKAP1 POLD1 AHCTF1 LRRC40 NR3C1 IPO4 PRPF8 KANK2 PDIA3 N4BP2 MACO1 TLN1 UBA6 LRRC61 CEP131 ESPL1 ATP2B4 | 7.72e-08 | 1487 | 285 | 34 | 33957083 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-19 ERVK-25 ERVK-24 ERVK-8 | 8.50e-08 | 94 | 285 | 9 | 21542922 |
| Pubmed | 1.45e-07 | 16 | 285 | 5 | 37225719 | ||
| Pubmed | A ubiquitin ligase complex assembles linear polyubiquitin chains. | 1.52e-07 | 7 | 285 | 4 | 17006537 | |
| Pubmed | The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor. | 1.52e-07 | 7 | 285 | 4 | 21685362 | |
| Pubmed | Priming and extending: a UbcH5/Cdc34 E2 handoff mechanism for polyubiquitination on a SCF substrate. | 1.52e-07 | 7 | 285 | 4 | 20347421 | |
| Pubmed | 1.52e-07 | 7 | 285 | 4 | 30884854 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GBF1 SMARCAD1 ADAR CRACD NCAPG NFKBIA A2ML1 ANKRD28 UQCRC1 LRRC41 ARMC8 ARID3A NACC1 PARP2 BTAF1 NR3C1 PRPF8 ECT2 KANK2 LENG9 TLE1 RTCA KDM1B SUFU | 2.09e-07 | 857 | 285 | 24 | 25609649 |
| Pubmed | 2.80e-07 | 18 | 285 | 5 | 18664271 | ||
| Pubmed | Ube2W conjugates ubiquitin to α-amino groups of protein N-termini. | 3.01e-07 | 8 | 285 | 4 | 23560854 | |
| Pubmed | 3.01e-07 | 8 | 285 | 4 | 29323787 | ||
| Pubmed | 5.39e-07 | 9 | 285 | 4 | 11807098 | ||
| Pubmed | Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment. | 5.45e-07 | 3 | 285 | 3 | 19712061 | |
| Pubmed | Identification of a family of closely related human ubiquitin conjugating enzymes. | 5.45e-07 | 3 | 285 | 3 | 8530467 | |
| Pubmed | 8.92e-07 | 10 | 285 | 4 | 31087003 | ||
| Pubmed | 8.92e-07 | 10 | 285 | 4 | 28757353 | ||
| Pubmed | The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway. | 1.06e-06 | 23 | 285 | 5 | 30017913 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | IFT140 CAND2 SCYL1 PSMC4 TRIM11 UBE2D2 AP2A2 CCDC154 PLCL2 ANKRD28 UQCRC1 TMEM231 PLS3 FYB2 ARMC8 MAPKAP1 ARID3A POLD1 CCDC150 MSH2 IPO4 PRPF8 ECT2 CLOCK PDIA3 ARL3 SH3PXD2A CEP131 CTSV | 1.68e-06 | 1321 | 285 | 29 | 27173435 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CAND1 GBF1 CAND2 PSMC4 CDKAL1 DLD ANKRD28 GNAS PLS3 VCP ARMC8 FLNB POLD1 MSH2 IPO4 PRPF8 KANK2 PDIA3 MACO1 PRKAB1 CSTF1 IRS2 SUFU ESPL1 | 1.99e-06 | 974 | 285 | 24 | 28675297 |
| Pubmed | The UbL protein UBTD1 stably interacts with the UBE2D family of E2 ubiquitin conjugating enzymes. | 2.08e-06 | 12 | 285 | 4 | 24211586 | |
| Pubmed | 2.16e-06 | 4 | 285 | 3 | 24293627 | ||
| Pubmed | Physical and functional interactions between ZIP kinase and UbcH5. | 2.16e-06 | 4 | 285 | 3 | 18515077 | |
| Pubmed | 2.16e-06 | 4 | 285 | 3 | 21134644 | ||
| Pubmed | Vinculin regulates assembly of talin: β3 integrin complexes. | 2.16e-06 | 4 | 285 | 3 | 24446374 | |
| Pubmed | Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. | 2.16e-06 | 4 | 285 | 3 | 27501245 | |
| Pubmed | 2.16e-06 | 4 | 285 | 3 | 7983737 | ||
| Pubmed | Functional interactions between ubiquitin E2 enzymes and TRIM proteins. | 2.48e-06 | 27 | 285 | 5 | 21143188 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | KNTC1 GBF1 MARS1 PSMC4 SNRK MAST2 MET NAA25 NCAPG UBE2D3 RAD54B UQCRC1 GNAS PLS3 VCP POLD1 PARP3 KLC2 MSH2 LRRK1 IPO4 PRPF8 STRIP1 TLE1 SUSD2 RTCA PRKAB1 IRS2 | 2.91e-06 | 1284 | 285 | 28 | 17353931 |
| Pubmed | Ubiquitination of STING at lysine 224 controls IRF3 activation. | 2.98e-06 | 13 | 285 | 4 | 28763789 | |
| Pubmed | 3.18e-06 | 144 | 285 | 9 | 35681168 | ||
| Pubmed | 4.14e-06 | 14 | 285 | 4 | 14690596 | ||
| Pubmed | 4.14e-06 | 14 | 285 | 4 | 36481767 | ||
| Pubmed | E3 ubiquitin ligase activity of the trifunctional ARD1 (ADP-ribosylation factor domain protein 1). | 5.38e-06 | 5 | 285 | 3 | 15684077 | |
| Pubmed | Systematic E2 screening reveals a UBE2D-RNF138-CtIP axis promoting DNA repair. | 5.38e-06 | 5 | 285 | 3 | 26502057 | |
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 10329681 | ||
| Pubmed | Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal. | 5.38e-06 | 5 | 285 | 3 | 25327252 | |
| Pubmed | The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase. | 5.38e-06 | 5 | 285 | 3 | 14562029 | |
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 23408431 | ||
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 19741096 | ||
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 19805288 | ||
| Pubmed | Activity-enhancing mutations in an E3 ubiquitin ligase identified by high-throughput mutagenesis. | 5.38e-06 | 5 | 285 | 3 | 23509263 | |
| Pubmed | A hypomorphic IgH-chain allele affects development of B-cell subsets and favours receptor editing. | 5.38e-06 | 5 | 285 | 3 | 21623346 | |
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 8090726 | ||
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 16413270 | ||
| Pubmed | 5.38e-06 | 5 | 285 | 3 | 31929179 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HIVEP2 GBF1 PLXND1 MAST2 JAK3 DST NBEAL2 TLN2 KIFC3 ARID3A NLRX1 BTAF1 LRRK1 INO80 ARHGAP35 NBPF1 ZNF503 TLN1 ENTPD2 DIP2C CEP131 IRS2 SUFU ESPL1 AGRN | 5.41e-06 | 1105 | 285 | 25 | 35748872 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CAND1 PSMC4 SRP19 SMARCAD1 NCAPG UBE2D1 TLN2 GNAS SEC23B POLD1 LRRC40 MSH2 BTAF1 PRPF8 ECT2 LENG9 TLN1 | 7.53e-06 | 582 | 285 | 17 | 20467437 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CAND1 MARS1 PSMC4 SMARCAD1 ADAR NAA35 NCAPG DST AP2A2 A2ML1 ANKRD28 UQCRC1 PLCG2 VCP FLNB RNF31 POLD1 AHCTF1 LRRC40 MSH2 IPO4 PRPF8 ECT2 PDIA3 TLN1 RTCA CSTF1 AGRN | 7.73e-06 | 1353 | 285 | 28 | 29467282 |
| Pubmed | CAND1 PDK1 MARS1 DAPK1 YJEFN3 ADD2 CRACD DST AP2A2 DLD TLN2 UQCRC1 PLS3 VCP ARMC8 FLNB KLC2 ARHGAP35 SHROOM2 KANK2 PDIA3 STRIP1 MLXIPL IGHM TLN1 LRRCC1 ATP1A3 ATP2B4 CACNA2D3 | 7.84e-06 | 1431 | 285 | 29 | 37142655 | |
| Pubmed | SMARCAD1 MAST2 ITGB3 ITPR1 DST CEP78 RAD54B ANKRD28 SEC23B LRRC41 MAPKAP1 RNF31 NOA1 BTAF1 NR3C1 ECT2 PARN AGRN | 8.39e-06 | 650 | 285 | 18 | 38777146 | |
| Pubmed | CNKSR1 CAND1 HIVEP2 CRIM1 SMARCAD1 NAA25 DST TLN2 CHD6 UQCRC1 KIFC3 UROD VCP ARMC8 KLHL4 FLNB VSNL1 APBB2 ANKRD6 PRPF8 SHROOM2 KANK2 TXNDC11 SLF2 LRRCC1 NEUROD6 ZNF292 | 8.63e-06 | 1285 | 285 | 27 | 35914814 | |
| Pubmed | IFT140 CAND1 CAND2 SNRK PLXND1 DST SMG7 ARHGAP31 NBEAL2 LRRK1 INO80 ERI2 CLOCK IGSF1 ESPL1 CEP57 | 9.11e-06 | 529 | 285 | 16 | 14621295 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 9.41e-06 | 208 | 285 | 10 | 33230847 | |
| Pubmed | 9.66e-06 | 17 | 285 | 4 | 33650289 | ||
| Pubmed | 9.66e-06 | 17 | 285 | 4 | 36563856 | ||
| Pubmed | 1.02e-05 | 257 | 285 | 11 | 16335952 | ||
| Pubmed | Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1. | 1.07e-05 | 6 | 285 | 3 | 22124327 | |
| Pubmed | h-Goliath, paralog of GRAIL, is a new E3 ligase protein, expressed in human leukocytes. | 1.07e-05 | 6 | 285 | 3 | 16549277 | |
| Pubmed | 1.07e-05 | 6 | 285 | 3 | 30404641 | ||
| Pubmed | Role of E2-RING Interactions in Governing RNF4-Mediated Substrate Ubiquitination. | 1.07e-05 | 6 | 285 | 3 | 27678051 | |
| Pubmed | 1.07e-05 | 6 | 285 | 3 | 15063128 | ||
| Pubmed | 1.07e-05 | 6 | 285 | 3 | 3036582 | ||
| Pubmed | 1.07e-05 | 6 | 285 | 3 | 22493083 | ||
| Pubmed | The E3 ubiquitin ligase TRIM32 regulates myoblast proliferation by controlling turnover of NDRG2. | 1.07e-05 | 6 | 285 | 3 | 25701873 | |
| Pubmed | Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo. | 1.07e-05 | 6 | 285 | 3 | 15280377 | |
| Pubmed | Negative regulation of the RLH signaling by the E3 ubiquitin ligase RNF114. | 1.07e-05 | 6 | 285 | 3 | 28625874 | |
| Pubmed | 1.07e-05 | 6 | 285 | 3 | 33962630 | ||
| Pubmed | Ubiquitin-Activated Interaction Traps (UBAITs) identify E3 ligase binding partners. | 1.20e-05 | 62 | 285 | 6 | 26508657 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 1.23e-05 | 18 | 285 | 4 | 12119179 | |
| Pubmed | 1.26e-05 | 130 | 285 | 8 | 12421765 | ||
| Pubmed | 1.55e-05 | 19 | 285 | 4 | 27425610 | ||
| Pubmed | KNTC1 GBF1 GALNT16 ABCA8 KRBA1 FAT2 AP2A2 PLEKHH2 TANGO6 ARHGAP35 ANKRD6 N4BP2 LRRCC1 DIP2C UNC80 | 1.62e-05 | 493 | 285 | 15 | 15368895 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KBTBD3 CAND1 HIVEP2 IL17REL MARS1 PFKFB1 YJEFN3 PTPRB SMG7 CHD6 UQCRC1 GNAS GPT2 LRRC41 FLNB AFF3 APBB2 SLITRK3 BTAF1 ARHGAP35 TECTA SHROOM2 LRRC8D NBPF1 CCNG2 SH3PXD2A UBA6 DIP2C NLK | 1.64e-05 | 1489 | 285 | 29 | 28611215 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | MARS1 PSMC4 KRBA1 PTPRB NBEAL2 ANKRD28 ANAPC4 HTR2B POLD1 KLC2 MEI1 PRPF8 UBA6 IRS2 ZNF292 | 1.78e-05 | 497 | 285 | 15 | 36774506 |
| Pubmed | CAND1 MARS1 ESR1 SRP19 INO80D CRACD DST KAT8 CHD6 UQCRC1 PLS3 ARMC8 MAPKAP1 POLD1 NOA1 AHCTF1 PARP2 INO80 IPO4 ECT2 KANK2 STRIP1 MACO1 TLN1 CSTF1 PARN CEP131 KDM1B AGRN | 1.81e-05 | 1497 | 285 | 29 | 31527615 | |
| Pubmed | 1.86e-05 | 40 | 285 | 5 | 30898150 | ||
| Pubmed | RNF122: a novel ubiquitin ligase associated with calcium-modulating cyclophilin ligand. | 1.86e-05 | 7 | 285 | 3 | 20553626 | |
| Pubmed | The E3 ubiquitin ligase MID1 catalyzes ubiquitination and cleavage of Fu. | 1.86e-05 | 7 | 285 | 3 | 25278022 | |
| Pubmed | 1.86e-05 | 7 | 285 | 3 | 33282879 | ||
| Pubmed | 1.86e-05 | 7 | 285 | 3 | 24831002 | ||
| Pubmed | 1.86e-05 | 7 | 285 | 3 | 17719635 | ||
| Pubmed | The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1. | 1.86e-05 | 7 | 285 | 3 | 30718280 | |
| Pubmed | 1.86e-05 | 7 | 285 | 3 | 20051513 | ||
| Pubmed | Measuring rates of ubiquitin chain formation as a functional readout of ligase activity. | 1.86e-05 | 7 | 285 | 3 | 22350887 | |
| Pubmed | 1.86e-05 | 7 | 285 | 3 | 34057440 | ||
| Pubmed | 1.89e-05 | 67 | 285 | 6 | 29357390 | ||
| Pubmed | 2.19e-05 | 102 | 285 | 7 | 11214970 | ||
| Pubmed | 2.20e-05 | 183 | 285 | 9 | 23956138 | ||
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | CAND1 MARS1 PSMC4 SMARCAD1 NCAPG UBE2D2 UBE2D3 AP2A2 A2ML1 UQCRC1 GNAS PLS3 SEC23B VCP MSH2 IPO4 | 2.32e-05 | 571 | 285 | 16 | 37167062 |
| Pubmed | Genetic loci associated with circulating levels of very long-chain saturated fatty acids. | 2.37e-05 | 42 | 285 | 5 | 25378659 | |
| Pubmed | 2.66e-05 | 43 | 285 | 5 | 26487511 | ||
| Pubmed | 2.96e-05 | 8 | 285 | 3 | 28972136 | ||
| Pubmed | 2.96e-05 | 8 | 285 | 3 | 18838541 | ||
| Pubmed | 2.96e-05 | 8 | 285 | 3 | 25207814 | ||
| Pubmed | A novel route for F-box protein-mediated ubiquitination links CHIP to glycoprotein quality control. | 2.96e-05 | 8 | 285 | 3 | 16682404 | |
| Interaction | RNF14 interactions | 3.19e-07 | 49 | 277 | 8 | int:RNF14 | |
| Interaction | TRIM33 interactions | CNKSR1 CAND1 MARS1 ESR1 HROB UBE2D2 UBE2D3 CEP78 ANKRD28 PLS3 VCP ANAPC4 RNF31 KLC2 MSH2 IPO4 PRPF8 ATP12A ZNF333 UNC80 | 5.08e-06 | 453 | 277 | 20 | int:TRIM33 |
| Interaction | BAG2 interactions | LRRK2 PSMC4 DAPK1 JAK3 TRIM11 PHLPP1 DLD WNK3 VCP TANGO6 ZNF703 RNF31 POLD1 KLC2 LRRC40 LRRK1 NR3C1 ARHGAP35 PRPF8 ECT2 ZNF503 TLN1 ESPL1 SKA1 | 5.81e-06 | 622 | 277 | 24 | int:BAG2 |
| Interaction | VN1R1 interactions | 1.02e-05 | 4 | 277 | 3 | int:VN1R1 | |
| Interaction | UBOX5 interactions | 1.30e-05 | 23 | 277 | 5 | int:UBOX5 | |
| Interaction | ARK2C interactions | 1.59e-05 | 12 | 277 | 4 | int:ARK2C | |
| Interaction | DTX3 interactions | 1.83e-05 | 108 | 277 | 9 | int:DTX3 | |
| Interaction | PLS3 interactions | GBF1 MARS1 ESR1 LRRK2 DLD PLS3 VCP FLNB POLD1 PRPF8 ECT2 PDIA3 TLN1 | 2.61e-05 | 237 | 277 | 13 | int:PLS3 |
| Interaction | ZNRF2 interactions | 4.27e-05 | 47 | 277 | 6 | int:ZNRF2 | |
| Interaction | RNF103 interactions | 4.29e-05 | 29 | 277 | 5 | int:RNF103 | |
| Interaction | TRIM10 interactions | 4.83e-05 | 48 | 277 | 6 | int:TRIM10 | |
| Interaction | FAM184A interactions | 5.90e-05 | 72 | 277 | 7 | int:FAM184A | |
| Interaction | MIB1 interactions | DAPK1 UBE2D1 UBE2D2 UBE2D3 SMG7 AP2A2 NR3C1 ARHGAP35 UBE2D4 SH3PXD2A N4BP2 MACO1 LRRCC1 CEP131 | 6.30e-05 | 295 | 277 | 14 | int:MIB1 |
| Cytoband | 8q11-q12 | 3.81e-05 | 2 | 284 | 2 | 8q11-q12 | |
| Cytoband | 3q12 | 3.77e-04 | 5 | 284 | 2 | 3q12 | |
| Cytoband | 4q12 | 3.82e-04 | 55 | 284 | 4 | 4q12 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 4.84e-05 | 40 | 182 | 5 | 321 | |
| GeneFamily | ATPase H+/K+ transporting | 3.00e-04 | 3 | 182 | 2 | 1211 | |
| GeneFamily | Ubiquitin conjugating enzymes E2 | 7.52e-04 | 41 | 182 | 4 | 102 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 8.63e-04 | 19 | 182 | 3 | 832 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.59e-03 | 50 | 182 | 4 | 1293 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | CAND2 DAPK1 RNF217 ITPR1 CRACD KRBA1 NAA25 NALF1 USH2A FLNB BNIP5 ARHGAP35 IPO4 KANK2 PPIC ZNF503 MLXIPL ARL3 NSG1 DIP2C ABCB11 TLE6 SUFU | 5.28e-08 | 574 | 276 | 23 | M8215 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | CAND2 DAPK1 RNF217 ITPR1 CRACD KRBA1 NAA25 NALF1 USH2A FLNB BNIP5 ARHGAP35 IPO4 KANK2 PPIC ZNF503 MLXIPL ARL3 NSG1 DIP2C ABCB11 TLE6 SUFU | 1.17e-07 | 600 | 276 | 23 | MM1025 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPHB2 CAND1 HIVEP2 GBF1 CRIM1 DAPK1 MAST2 ITPR1 UBE2D2 UBE2D3 DST NALF1 ATAD2B PHLPP1 ANKRD28 FLNB AHCTF1 APBB2 MSH2 BTAF1 NR3C1 ARHGAP35 CLOCK TIA1 TLE1 PARN ATP2B4 ZNF292 | 1.30e-07 | 856 | 276 | 28 | M4500 |
| Coexpression | GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP | PLXND1 PARP2 SLITRK3 MSH2 PRPF8 ECT2 KANK2 LRRC8D CCNG2 ARL3 DYNC2LI1 DIP2C | 1.55e-06 | 200 | 276 | 12 | M3404 |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | KNTC1 STYK1 HROB NCAPG CEP78 ARHGAP31 RAD54B ARID3A SLC44A2 KLC2 MSH2 MZT1 ECT2 CCNG2 P2RX7 CUZD1 LRRCC1 PLD5 ESPL1 SKA1 | 4.91e-06 | 588 | 276 | 20 | M38992 |
| Coexpression | GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP | TNFSF14 ADAR CXCR5 NAA25 CHD6 CERS4 ABI3BP APLF SLF2 SUSD2 ATP12A | 9.25e-06 | 199 | 276 | 11 | M5105 |
| Coexpression | GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN | CRIM1 STYK1 INO80D HROB UBE2D2 NBEAL2 ANKRD28 USP1 ZNF703 LRRC40 NR3C1 | 9.70e-06 | 200 | 276 | 11 | M327 |
| Coexpression | GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_DN | AP2A2 ATAD2B NFKBIA PLS3 SLC44A2 MZT1 PPIC TIA1 ERRFI1 CSTF1 CTSV | 9.70e-06 | 200 | 276 | 11 | M7884 |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | PDGFRA ABCA8 DST FGFR4 KIFC3 PLEKHH2 ABI3BP CD8A DYNC2LI1 IRS2 | 1.01e-05 | 164 | 276 | 10 | M41676 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_DN | 1.77e-05 | 175 | 276 | 10 | M6818 | |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | 1.96e-05 | 177 | 276 | 10 | M9401 | |
| Coexpression | GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN | HIVEP2 TNFSF14 BPIFB1 ITPR1 PHLPP1 PLCB2 SLC44A2 P2RX7 SUSD2 IL2RB | 2.26e-05 | 180 | 276 | 10 | M8898 |
| Coexpression | GARY_CD5_TARGETS_UP | PDK1 MARS1 MAST2 NBEAL2 KAT8 NFKBIA UQCRC1 ALDH6A1 LRRC41 SLC44A2 APBB2 DYNC2LI1 IGHM TLN1 AGRN NLK | 4.71e-05 | 473 | 276 | 16 | M17693 |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | LRRK2 FAM13B INO80D ATAD2B CHD6 NR3C1 CLOCK SH3PXD2A TLN1 ZNF292 | 5.54e-05 | 200 | 276 | 10 | M9463 |
| Coexpression | GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP | IFT140 HIVEP2 CRIM1 ITPR1 CXCR5 JAK3 TRIM11 AP2A2 SLC44A2 POLI | 5.54e-05 | 200 | 276 | 10 | M7841 |
| Coexpression | GSE3982_BCELL_VS_BASOPHIL_DN | ADCY10 CRIM1 DBH UBE2D3 FAM186A GNAS SEC23B SNCAIP ATP2B4 NLK | 5.54e-05 | 200 | 276 | 10 | M5540 |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | HIVEP2 CRIM1 PDK1 DIPK1A CXCR5 CEP78 VNN1 CERS4 FLNB NOA1 AHCTF1 AFF3 MSH2 PRPF8 CD8A N4BP2 TLE1 IGHM NSG1 LY9 FBXL20 CEP57 IL2RB ATP2B4 ZNF292 | 7.62e-05 | 1012 | 276 | 25 | M40864 |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | CAND1 GBF1 DAPK1 CHD6 GNAS USP1 APBB2 BTAF1 NR3C1 ECT2 APLF TLE1 ERRFI1 HACL1 PARN | 7.62e-05 | 441 | 276 | 15 | M172 |
| Coexpression | WILLERT_WNT_SIGNALING | 9.10e-05 | 23 | 276 | 4 | M1805 | |
| Coexpression | GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_DN | 9.21e-05 | 172 | 276 | 9 | M6816 | |
| Coexpression | PYEON_HPV_POSITIVE_TUMORS_UP | 9.84e-05 | 101 | 276 | 7 | M7738 | |
| Coexpression | FISCHER_DREAM_TARGETS | KNTC1 CAND1 MARS1 CDKAL1 HROB NCAPG UBE2D3 CEP78 RAD54B USP1 POLD1 AHCTF1 PARP2 CCDC150 MSH2 MZT1 ECT2 SLF2 LRRCC1 ZMYM1 FBXL20 ESPL1 SKA1 CEP57 | 1.02e-04 | 969 | 276 | 24 | M149 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | HIVEP2 TNFSF14 SNRK ADAR FAM13B INO80D ITPR1 JAK3 UBE2D2 UBE2D3 NBEAL2 NFKBIA TRPV2 ANKRD28 PLCB2 GNAS USP1 CASP1 BTAF1 NR3C1 ARHGAP35 PRPF8 CD8A SLF2 PRF1 TLN1 LY9 FBXL20 IL2RB ATP2B4 SENP7 ZNF292 | 1.10e-04 | 1492 | 276 | 32 | M40023 |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN | 1.25e-04 | 179 | 276 | 9 | M16932 | |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP | 1.36e-04 | 181 | 276 | 9 | M6323 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP | 1.47e-04 | 183 | 276 | 9 | M12621 | |
| Coexpression | SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN | 1.57e-04 | 145 | 276 | 8 | M11513 | |
| Coexpression | ONDER_CDH1_TARGETS_2_DN | DIPK1A DHRS1 ITGB6 FAT2 DST NBEAL2 FLNB VSNL1 CASP1 CCNG2 NSG1 ATP12A CTSV AGRN ATP2B4 | 1.64e-04 | 473 | 276 | 15 | M4306 |
| Coexpression | RPS14_DN.V1_DN | 1.67e-04 | 186 | 276 | 9 | M2812 | |
| Coexpression | NABA_CORE_MATRISOME | CRIM1 COL22A1 USH2A VWA2 COL12A1 ABI3BP TECTA MMRN1 EYS TNN AGRN | 1.74e-04 | 275 | 276 | 11 | M5884 |
| Coexpression | GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.98e-04 | 150 | 276 | 8 | M9139 | |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | HIVEP2 PDGFRA ABCA8 CXCR5 MET DST PLCL2 PLCB2 CASP1 SNCAIP CD8A PRF1 IGHM NSG1 LY9 | 2.15e-04 | 485 | 276 | 15 | M8513 |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S2 | 2.21e-04 | 115 | 276 | 7 | M7995 | |
| Coexpression | SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP | 2.31e-04 | 82 | 276 | 6 | M9224 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.46e-04 | 196 | 276 | 9 | M3008 | |
| Coexpression | GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_UP | 2.56e-04 | 197 | 276 | 9 | M9725 | |
| Coexpression | ERBB2_UP.V1_DN | 2.56e-04 | 197 | 276 | 9 | M2635 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP | 2.65e-04 | 198 | 276 | 9 | M7046 | |
| Coexpression | GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN | CRIM1 PLXND1 ARHGAP31 NBEAL2 NR3C1 ARHGAP35 ATP1A3 SUFU ATP2B4 | 2.65e-04 | 198 | 276 | 9 | M6511 |
| Coexpression | GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN | 2.75e-04 | 199 | 276 | 9 | M6199 | |
| Coexpression | GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN | 2.75e-04 | 199 | 276 | 9 | M6507 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 2.86e-04 | 200 | 276 | 9 | M9472 | |
| Coexpression | GSE27786_BCELL_VS_MONO_MAC_UP | 2.86e-04 | 200 | 276 | 9 | M4817 | |
| Coexpression | GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN | 2.86e-04 | 200 | 276 | 9 | M3571 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN | 2.86e-04 | 200 | 276 | 9 | M7150 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN | 2.86e-04 | 200 | 276 | 9 | M7518 | |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_UP | 2.86e-04 | 200 | 276 | 9 | M8775 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP | 2.86e-04 | 200 | 276 | 9 | M6640 | |
| Coexpression | GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_DN | 2.86e-04 | 200 | 276 | 9 | M6894 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_TH1_DN | 2.86e-04 | 200 | 276 | 9 | M5423 | |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP | 2.86e-04 | 200 | 276 | 9 | M4332 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | KNTC1 PDK1 DIPK1A ESR1 GRIK4 LRRK1 MEI1 TXNDC11 PLXNC1 IGHM LY9 | 1.90e-08 | 181 | 276 | 11 | 6cdee2f56bc633b387b4dbbd78c624edbd712c24 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | KNTC1 PDK1 DIPK1A ESR1 GRIK4 LRRK1 MEI1 TXNDC11 PLXNC1 IGHM LY9 | 1.90e-08 | 181 | 276 | 11 | b75b8b025257bccfe661fd0f92ab284b2a9c12ee |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-Naive_B_cells|GI_large-bowel / Manually curated celltypes from each tissue | 2.38e-08 | 185 | 276 | 11 | 1c99373c123b5e0de40b47d9d885974a747b9839 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | KNTC1 PDK1 DIPK1A ESR1 NCAPG ANKRD28 PLCG2 LRRK1 MEI1 TXNDC11 IGHM | 2.51e-08 | 186 | 276 | 11 | 66676d9395172de5707e204826a1c9f73b448cca |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADCY10 ABCA13 COL22A1 OTOGL USH2A TECTA ABCB11 ATP12A MYO15A UNC80 | 2.55e-08 | 145 | 276 | 10 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 |
| ToppCell | COVID-19-kidney-Plasma|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.50e-08 | 160 | 276 | 10 | f8d9e459976e711e9ad39ea2b6173140c0589d6e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HIVEP2 ABCA13 COL22A1 OTOGL NFKBIA USH2A UBD PLD5 ATP12A UNC80 | 1.09e-07 | 169 | 276 | 10 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CSMD2 ITGB3 MET CRACD PLEKHH2 GRIK4 EYS SNCAIP SNTG1 NEUROD6 | 1.35e-07 | 173 | 276 | 10 | 2e35bf2b5534a289d93a09faae660f665c131062 |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal|TCGA-Colorectal / Sample_Type by Project: Shred V9 | SCN11A GCNT2 ABCA8 LILRB5 ABI3BP AFF3 FAM135B MMRN1 CBLN2 MUSK | 2.06e-07 | 181 | 276 | 10 | 88f6f56f5f58b479d5db91b32c45934c045f88ea |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-07 | 139 | 276 | 9 | 4ddfbc36a0560fb70594627178bff652ab1ea3e9 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-07 | 139 | 276 | 9 | 82bf5ba69a907fbd9b4e2b2dd1dd27b8c4c75f25 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-07 | 139 | 276 | 9 | fc9ac09c2106e88104a52575832d71d17765eec8 | |
| ToppCell | facs-Liver-Hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-07 | 139 | 276 | 9 | fc4b39ac9a10cf0acacfebbc4295edf324d930d5 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | KNTC1 PDK1 DIPK1A ESR1 ANKRD28 PLCG2 LRRK1 MEI1 TXNDC11 IGHM | 2.53e-07 | 185 | 276 | 10 | 3b77bc49cd3740acc025e162a36282ac09e12198 |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.53e-07 | 185 | 276 | 10 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | KNTC1 PDK1 DIPK1A ESR1 NCAPG ANKRD28 LRRK1 MEI1 TXNDC11 IGHM | 2.93e-07 | 188 | 276 | 10 | 567b08514d9d84cbb40f9b7a679eec304f023428 |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | CRIM1 DAPK1 ITPR1 PTPRB NALF1 ARHGAP31 FLNB SHROOM2 MMRN1 TLE1 | 3.08e-07 | 189 | 276 | 10 | c81787a8c662db5d7814c583dd64562857629e81 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.10e-07 | 195 | 276 | 10 | 69201b1172bcf0999c726516e4d30863afceab0b | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.51e-07 | 197 | 276 | 10 | 0f489d26e4013d1b5a90559856ed2de32a0bb772 | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | TNFSF14 LRRK2 ITGB6 MET NFKBIA PLEKHH2 SFTPD SLC26A9 SUSD2 ERRFI1 | 4.51e-07 | 197 | 276 | 10 | b22a79a5922c865a360e2afc5506a08a512fa76a |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-07 | 198 | 276 | 10 | 567fcf882c8612356946240843525b786f3c8dbe | |
| ToppCell | Sigmoid-(2)_B_cell-(23)_Follicular_B_cell|Sigmoid / shred on region, Cell_type, and subtype | 4.72e-07 | 198 | 276 | 10 | bfb1aa1450d1afb14b875e0cf6796e1a715b4605 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | HIVEP2 ITPR1 NALF1 GNAS VSNL1 AFF3 SNTG1 ATP1A3 UNC80 CACNA2D3 | 4.72e-07 | 198 | 276 | 10 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 |
| ToppCell | Sigmoid-B_cell-Follicular_B_cell|Sigmoid / Region, Cell class and subclass | 4.72e-07 | 198 | 276 | 10 | c3507fb508ace85a31dcff323f9e7ddb9ae6862e | |
| ToppCell | Caecum-(5)_Dendritic_cell-(51)_cDC1|Caecum / shred on region, Cell_type, and subtype | LRRK2 DAPK1 RNF217 DST SIGLEC10 PHLPP1 SFTPD PPIC ZNF503 LRRCC1 | 4.95e-07 | 199 | 276 | 10 | 2b97fda45241b2ce7be904cf081cabcf3eb5ba1d |
| ToppCell | Caecum-Dendritic_cell-cDC1|Caecum / Region, Cell class and subclass | LRRK2 DAPK1 RNF217 DST SIGLEC10 PHLPP1 SFTPD PPIC ZNF503 LRRCC1 | 4.95e-07 | 199 | 276 | 10 | 9ab38a0060a883de6fe3da8cdac42e124d7981d9 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.53e-07 | 158 | 276 | 9 | 6b51e5ee08e23924f5edbaf0a845a9232fb7ff7a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.53e-07 | 158 | 276 | 9 | 8dd83a2a4c2ec9cdc3a03df8b51ee22bee1c2888 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 169 | 276 | 9 | 4ac21e8199de4b6917eacadc56fffc6d886ee643 | |
| ToppCell | COVID-19-kidney-Plasma|kidney / Disease (COVID-19 only), tissue and cell type | 1.26e-06 | 171 | 276 | 9 | a59a054b8e119215f24dc5c80ad5a8094b3500f9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-06 | 175 | 276 | 9 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | Control-B_cells-Plasma_cells|Control / group, cell type (main and fine annotations) | 1.53e-06 | 175 | 276 | 9 | fb23858cfce71509cafbe0d9728e678012ff2962 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-06 | 177 | 276 | 9 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.85e-06 | 179 | 276 | 9 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-06 | 181 | 276 | 9 | 5a4fe0eca7cbc9cbc8a2fdbe795a7c5f4052a659 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 2.21e-06 | 183 | 276 | 9 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 2.21e-06 | 183 | 276 | 9 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 2.21e-06 | 183 | 276 | 9 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-06 | 183 | 276 | 9 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 184 | 276 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 184 | 276 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 184 | 276 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.64e-06 | 187 | 276 | 9 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.76e-06 | 188 | 276 | 9 | 599195338070ac6b79bd114609d9e10cac4f1df4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ABCA13 LRRK2 DAPK1 ITGB6 CDKAL1 MET PLEKHH2 DYNC2LI1 CACNA2D3 | 2.76e-06 | 188 | 276 | 9 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-06 | 189 | 276 | 9 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 2.89e-06 | 189 | 276 | 9 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-06 | 190 | 276 | 9 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | EPHB2 ABCA13 LRRK2 DAPK1 ITGB6 MET PLEKHH2 DYNC2LI1 CACNA2D3 | 3.15e-06 | 191 | 276 | 9 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 191 | 276 | 9 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 191 | 276 | 9 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 3.15e-06 | 191 | 276 | 9 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | B_cells-Memory_B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.28e-06 | 192 | 276 | 9 | eef591095921ede098f41a2b81897b18915bb753 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.28e-06 | 192 | 276 | 9 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 3.42e-06 | 193 | 276 | 9 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.42e-06 | 193 | 276 | 9 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-06 | 193 | 276 | 9 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.57e-06 | 194 | 276 | 9 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 3.57e-06 | 194 | 276 | 9 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.73e-06 | 195 | 276 | 9 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 3.73e-06 | 195 | 276 | 9 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.88e-06 | 196 | 276 | 9 | fd18a9ae8401121ae276adff1a85d5f938e2df91 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-Memory_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 3.88e-06 | 196 | 276 | 9 | c450cd6b799932f5cce8326d1079114abeb71e95 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.05e-06 | 197 | 276 | 9 | da61afba697ec49ca86e062d35a825280da558ac | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.05e-06 | 197 | 276 | 9 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.05e-06 | 197 | 276 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 4.05e-06 | 197 | 276 | 9 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.05e-06 | 197 | 276 | 9 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.05e-06 | 197 | 276 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 4.22e-06 | 198 | 276 | 9 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.22e-06 | 198 | 276 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.39e-06 | 199 | 276 | 9 | 1bb02f41f3cc76a28581e38b0ca4c36b930b85b4 | |
| ToppCell | distal-Endothelial-Vein-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.39e-06 | 199 | 276 | 9 | f9fc0482d7ab11f2165b30cce3564b4ff87d61a6 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.39e-06 | 199 | 276 | 9 | 2f60682f1b82918a65e8851e99c9e3398845b62f | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.39e-06 | 199 | 276 | 9 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.39e-06 | 199 | 276 | 9 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.39e-06 | 199 | 276 | 9 | 1aa963ed5205d6d52262b1597a5d08707a95c3ca | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.39e-06 | 199 | 276 | 9 | 58242d78517c05fa367a7c6edac57ef79107453c | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 4.58e-06 | 200 | 276 | 9 | 4e489ecf472857357d45e9f6c7a812aa48b72ebf | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.58e-06 | 200 | 276 | 9 | e1b3fc516887510b18cf688ada0e00b5f5eff684 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.58e-06 | 200 | 276 | 9 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Sigmoid-(1)_T_cell-(18)_cycling_gd_T|Sigmoid / shred on region, Cell_type, and subtype | 4.58e-06 | 200 | 276 | 9 | 6e367abd1a4b87e20eb9095b8337723163e8bbae | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 4.58e-06 | 200 | 276 | 9 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|Sigmoid / Region, Cell class and subclass | 4.58e-06 | 200 | 276 | 9 | 9769185abae084ffac36420c749625e679b70ca8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 4.58e-06 | 200 | 276 | 9 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 4.58e-06 | 200 | 276 | 9 | 203b9a5de4430713da01b3331e69381db449a3a0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 4.58e-06 | 200 | 276 | 9 | a854e19703dc920e48304541e2b06ed013292f3e | |
| ToppCell | Biopsy_IPF-Epithelial-KRT5-/KRT17+|Biopsy_IPF / Sample group, Lineage and Cell type | 4.58e-06 | 200 | 276 | 9 | 2fc7a3b3aea711ad3d96fd9513f4b40533056d86 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-06 | 158 | 276 | 8 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-06 | 158 | 276 | 8 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.90e-06 | 159 | 276 | 8 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.90e-06 | 159 | 276 | 8 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.90e-06 | 159 | 276 | 8 | 7c2f70a7cba880115ccd676fb6c5f18488a5b74f | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 160 | 276 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.23e-06 | 160 | 276 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.92e-06 | 162 | 276 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-05 | 168 | 276 | 8 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-05 | 168 | 276 | 8 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-05 | 168 | 276 | 8 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.08e-05 | 169 | 276 | 8 | 84b898a9fd8ced67c6a501d5cef6416f519902c4 | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; MCF7; HT_HG-U133A | EPHB2 ITIH2 ITPR1 PLCB2 UROD CERS4 PARP3 PHF7 LRRK1 NR3C1 MLXIPL MYO15A IL2RB | 1.01e-06 | 198 | 277 | 13 | 2264_UP |
| Drug | Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; MCF7; HT_HG-U133A | EPHB2 IFT140 ADD2 PLCL2 CERS4 APBB2 NR3C1 VN1R1 CUZD1 ATP1A3 MUC2 IL2RB MUSK | 1.13e-06 | 200 | 277 | 13 | 3503_UP |
| Drug | Sulcrate | KNTC1 MARS1 CARD16 PLCB2 PLCG2 GNAS UROD GPT2 CASP1 P2RX7 ATP12A | 2.08e-06 | 148 | 277 | 11 | CID006398525 |
| Drug | Imipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | IFT140 CRIM1 ESR1 PLXND1 KAT8 ALDH6A1 ARID3A ARHGAP35 TLN1 IGSF1 ATP2B4 NLK | 4.16e-06 | 191 | 277 | 12 | 5997_DN |
| Drug | Simvastatin [79902-63-9]; Down 200; 9.6uM; HL60; HT_HG-U133A | IFT140 ITGB6 PTPRB SMG7 ALDH6A1 LRRC41 APBB2 DYNC2LI1 ZNF415 CTSV AGRN NLK | 5.43e-06 | 196 | 277 | 12 | 3002_DN |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; HL60; HT_HG-U133A | IFT140 INO80D ITGB6 SMG7 GNAS TMEM231 ALDH6A1 LRRC41 PLXNC1 DYNC2LI1 SH3PXD2A MUC2 | 5.72e-06 | 197 | 277 | 12 | 2994_DN |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; MCF7; HT_HG-U133A | EPHB2 ESR1 ITGB3 ITPR1 FGFR4 UROD NR3C1 ARHGAP35 PRF1 TLE1 CUZD1 IL2RB | 5.72e-06 | 197 | 277 | 12 | 3832_UP |
| Drug | Acyclovir [59277-89-3]; Up 200; 17.8uM; MCF7; HT_HG-U133A | STYK1 ITIH2 CDKAL1 HROB UROD APBB2 VN1R1 CCNG2 MLXIPL CD8A IRS2 SENP7 | 5.72e-06 | 197 | 277 | 12 | 1543_UP |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; PC3; HT_HG-U133A | EPHB2 SCN11A ESR1 CDKAL1 JAK3 SMG7 PLCL2 LRRK1 PLXNC1 SH3PXD2A PRF1 MYO15A | 6.02e-06 | 198 | 277 | 12 | 4446_UP |
| Drug | AC1L1B6T | 6.12e-06 | 38 | 277 | 6 | CID000001308 | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; MCF7; HT_HG-U133A | SCN11A ESR1 INO80D CDKAL1 ADD2 NLRX1 CR1 VN1R1 P2RX7 SNTG1 IL2RB ATP2B4 | 6.67e-06 | 200 | 277 | 12 | 2769_UP |
| Drug | AC1L9OLY | 9.20e-06 | 141 | 277 | 10 | CID000424898 | |
| Drug | 0297417-0002B [362658-29-5]; Up 200; 10uM; MCF7; HT_HG-U133A | ESR1 INO80D UBE2D1 NFKBIA KIFC3 GNAS ALDH6A1 NR3C1 CCNG2 TLE1 IRS2 | 1.85e-05 | 186 | 277 | 11 | 6900_UP |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | EPHB2 ESR1 MAST2 CPED1 NALF1 GNAS APBB2 LRRK1 MACO1 ZNF415 SENP7 | 2.15e-05 | 189 | 277 | 11 | 5084_DN |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | PDGFRA ITPR1 MET GNAS PHF7 LRRK1 NR3C1 CCNG2 TLN1 UBA6 LRRC61 | 2.73e-05 | 194 | 277 | 11 | 4341_DN |
| Drug | Pentamidine isethionate [140-64-7]; Up 200; 6.8uM; PC3; HT_HG-U133A | IFT140 PDGFRA ITGB3 KAT8 ATAD2B PLCL2 PHF7 LRRK1 MACO1 MUC2 CTSV | 2.73e-05 | 194 | 277 | 11 | 4573_UP |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | HIVEP2 DIPK1A SNRK MET SMG7 ABI3BP APBB2 ARHGAP35 SHROOM2 UBE2D4 SKA1 | 2.73e-05 | 194 | 277 | 11 | 4662_DN |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | EPHB2 PDK1 ESR1 GCNT2 MAST2 RAD54B FGFR4 FLNB NLRX1 TLE1 LRRC61 | 2.87e-05 | 195 | 277 | 11 | 2223_DN |
| Drug | Felbinac [5728-52-9]; Down 200; 18.8uM; MCF7; HT_HG-U133A | ESR1 SNRK GCNT2 NALF1 FGFR4 GNAS APBB2 ANKRD6 ZNF750 LRRC61 IRS2 | 3.01e-05 | 196 | 277 | 11 | 5700_DN |
| Drug | Estriol [50-27-1]; Up 200; 13.8uM; MCF7; HT_HG-U133A | EPHB2 ESR1 ITGB3 ITPR1 AP2A2 GNAS PHF7 CR1 TNN ATP1A3 ATP12A | 3.01e-05 | 196 | 277 | 11 | 3563_UP |
| Drug | S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; MCF7; HT_HG-U133A | DAPK1 ITPR1 MET RAD54B TLN2 FGFR4 CASP1 PHF7 NR3C1 ANKRD6 CCNG2 | 3.15e-05 | 197 | 277 | 11 | 6471_UP |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A | HIVEP2 PDK1 CDKAL1 UBE2D1 UBE2D2 KAT8 RAD54B CASP1 ARHGAP35 ANKRD6 CD8A | 3.15e-05 | 197 | 277 | 11 | 5387_DN |
| Drug | Pentylenetetrazole [54-95-5]; Up 200; 29uM; HL60; HG-U133A | CAND1 FAM13B KAT8 ATAD2B ALDH6A1 APBB2 ARHGAP35 MLXIPL CDH22 ATP2B4 NLK | 3.15e-05 | 197 | 277 | 11 | 1408_UP |
| Drug | Lorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; PC3; HT_HG-U133A | SCN11A ESR1 ABCA8 CDKAL1 MET HTR2B SFTPD PHF7 P2RX7 NSG1 MUC2 | 3.15e-05 | 197 | 277 | 11 | 4658_UP |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; HL60; HT_HG-U133A | INO80D ITGB6 LRRC41 APBB2 ANKRD6 UBE2D4 PLXNC1 PRF1 TLE1 CEP131 MUC2 | 3.15e-05 | 197 | 277 | 11 | 3006_DN |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A | EPHB2 HIVEP2 CDKAL1 KIFC3 ALDH6A1 RNF31 NR3C1 SHROOM2 SLF2 DIP2C ZNF292 | 3.15e-05 | 197 | 277 | 11 | 1810_DN |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; MCF7; HT_HG-U133A | IFT140 ITGB3 INO80D AP2A2 CERS4 VN1R1 MLXIPL SNCAIP CD8A TLE1 IL2RB | 3.15e-05 | 197 | 277 | 11 | 3382_UP |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | ITPR1 HROB SMG7 TLN2 UROD NLRX1 APBB2 ARHGAP35 UBE2D4 LRRC61 IL2RB | 3.30e-05 | 198 | 277 | 11 | 5213_UP |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | EPHB2 IFT140 GBF1 PDK1 INO80D CDKAL1 NR3C1 ARHGAP35 CCNG2 ZMYM1 IGSF1 | 3.30e-05 | 198 | 277 | 11 | 5019_DN |
| Drug | Lactobionic acid [96-82-2]; Down 200; 11.2uM; HL60; HT_HG-U133A | CDKAL1 SMG7 FLNB APBB2 LRRK1 CCNG2 TIA1 PLXNC1 TLE1 ZMYM1 AGRN | 3.30e-05 | 198 | 277 | 11 | 1309_DN |
| Drug | cadmium | MARS1 ESR1 ADAR ITIH2 NFKBIA DLD UROD GPT2 ALDH6A1 PLS3 VCP ANAPC4 MSH2 CD8A TIA1 IL2RB CACNA2D3 | 3.37e-05 | 443 | 277 | 17 | CID000002514 |
| Drug | Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; PC3; HT_HG-U133A | SCN11A ESR1 SNRK PLXND1 INO80D AP2A2 RAD54B CASP1 PHF7 TLE1 SENP7 | 3.46e-05 | 199 | 277 | 11 | 6640_DN |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; MCF7; HT_HG-U133A | SCN11A ITGB3 ITIH2 ADD2 JAK3 NALF1 CERS4 SNCAIP CD8A TLN1 LRRC61 | 3.46e-05 | 199 | 277 | 11 | 2302_UP |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A | SCN11A GCNT2 ITIH2 VNN1 GNAS ALDH6A1 VSNL1 PHF7 TECTA TLE1 AGRN | 3.46e-05 | 199 | 277 | 11 | 2677_UP |
| Drug | THIP Hydrochloride; Up 200; 22.6uM; MCF7; HT_HG-U133A | SCN11A ESR1 ITGB3 CDKAL1 ABI3BP ARHGAP35 UBE2D4 TLE1 TLN1 ZNF415 MUSK | 3.46e-05 | 199 | 277 | 11 | 6511_UP |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; MCF7; HT_HG-U133A | EPHB2 ADCY10 ESR1 VSNL1 ARHGAP35 CCNG2 ZNF750 CD8A PRF1 CUZD1 ATP12A | 3.46e-05 | 199 | 277 | 11 | 6462_UP |
| Drug | Isoconazole [27523-40-6]; Up 200; 9.6uM; PC3; HT_HG-U133A | EPHB2 ESR1 PLXND1 INO80D HROB RAD54B UROD LRRK1 MACO1 CUZD1 NEUROD6 | 3.46e-05 | 199 | 277 | 11 | 5857_UP |
| Drug | Riboflavine [83-88-5]; Up 200; 10.6uM; PC3; HT_HG-U133A | ADD2 SMG7 KAT8 TLN2 FGFR4 APBB2 ARHGAP35 MTERF4 SH3PXD2A NSG1 CUZD1 | 3.46e-05 | 199 | 277 | 11 | 4485_UP |
| Drug | Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; MCF7; HT_HG-U133A | EPHB2 PDGFRA ESR1 ITIH2 MET NALF1 PARP3 CASP1 CD8A P2RX7 TLN1 | 3.46e-05 | 199 | 277 | 11 | 2298_UP |
| Drug | Ascorbic acid [50-81-7]; Down 200; 22.4uM; MCF7; HT_HG-U133A | HIVEP2 CRIM1 PDK1 ESR1 INO80D AP2A2 CASP1 ARHGAP35 MTERF4 CD8A TLE1 | 3.46e-05 | 199 | 277 | 11 | 5407_DN |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | MARS1 ESR1 RAD54B TLN2 KLC2 NR3C1 SLF2 ZMYM1 IGSF1 SKA1 ZNF292 | 3.62e-05 | 200 | 277 | 11 | 3465_DN |
| Drug | Pl-cs | 5.00e-05 | 107 | 277 | 8 | CID006450086 | |
| Drug | 1,5-isoquinolinediol | 5.36e-05 | 34 | 277 | 5 | CID000001340 | |
| Drug | catalpol | 6.01e-05 | 7 | 277 | 3 | CID000091520 | |
| Drug | AC1NMIA2 | 7.20e-05 | 19 | 277 | 4 | CID005051378 | |
| Drug | hydrochalcone | 9.54e-05 | 8 | 277 | 3 | CID000064802 | |
| Drug | Tamoxifen citrate [54965-24-1]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.03e-04 | 187 | 277 | 10 | 6768_UP | |
| Drug | nonadecane | 1.09e-04 | 21 | 277 | 4 | CID000012401 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 1.18e-04 | 190 | 277 | 10 | 6956_UP | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | CAND2 PDGFRA GCNT2 ITPR1 NAA35 GNAS APBB2 TIA1 CEP131 ZNF292 | 1.18e-04 | 190 | 277 | 10 | 7145_DN |
| Drug | Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; HL60; HT_HG-U133A | 1.28e-04 | 192 | 277 | 10 | 2580_UP | |
| Drug | 5f-1 | 1.32e-04 | 22 | 277 | 4 | CID015991535 | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; PC3; HT_HG-U133A | PTPRB SMG7 ALDH6A1 CASP1 ARHGAP35 TLN1 ATP1A3 LY9 MYO15A AGRN | 1.34e-04 | 193 | 277 | 10 | 4240_DN |
| Drug | Oxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A | EPHB2 SCN11A ESR1 STYK1 ITGB3 FGFR4 CASP1 MLXIPL SH3PXD2A SNTG1 | 1.34e-04 | 193 | 277 | 10 | 3344_UP |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.40e-04 | 194 | 277 | 10 | 3194_UP | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.40e-04 | 194 | 277 | 10 | 3855_UP | |
| Drug | Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | MAST2 UBE2D1 PHLPP1 FGFR4 LRRC41 SHROOM2 CCNG2 DYNC2LI1 TLN1 SKA1 | 1.40e-04 | 194 | 277 | 10 | 3460_DN |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | ESR1 SMG7 AP2A2 ALDH6A1 APBB2 NR3C1 ARHGAP35 VN1R1 CCNG2 CTSV | 1.40e-04 | 194 | 277 | 10 | 1632_UP |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | IFT140 MAST2 VNN1 TLN2 LRRC41 PHF7 VN1R1 PLXNC1 LY9 CACNA2D3 | 1.40e-04 | 194 | 277 | 10 | 2684_DN |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | MARS1 ESR1 MAST2 CDKAL1 CASP1 ARHGAP35 ZNF750 DYNC2LI1 LRRC61 IL2RB | 1.46e-04 | 195 | 277 | 10 | 5631_DN |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.46e-04 | 195 | 277 | 10 | 3571_DN | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; PC3; HT_HG-U133A | EPHB2 CAND1 PLXND1 SMG7 TLN2 ALDH6A1 PARP3 ARHGAP35 SHROOM2 PRKAB1 | 1.46e-04 | 195 | 277 | 10 | 7377_UP |
| Drug | SB 202190; Down 200; 1uM; MCF7; HT_HG-U133A | 1.46e-04 | 195 | 277 | 10 | 7054_DN | |
| Drug | Sulfadoxine [2447-57-6]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.46e-04 | 195 | 277 | 10 | 3547_UP | |
| Drug | Diphenyl Ether Sulfonamide 10 | 1.47e-04 | 2 | 277 | 2 | CID009887536 | |
| Drug | tubacin | 1.47e-04 | 2 | 277 | 2 | ctd:C474316 | |
| Drug | Gonadotropin-Releasing Hormone | 1.47e-04 | 2 | 277 | 2 | ctd:D007987 | |
| Drug | Diphenyl Ether Sulfonamide 2 | 1.47e-04 | 2 | 277 | 2 | CID015888281 | |
| Drug | Diphenyl Ether Sulfonamide 9 | 1.47e-04 | 2 | 277 | 2 | CID015888283 | |
| Drug | Diphenyl Ether Sulfonamide 5 | 1.47e-04 | 2 | 277 | 2 | CID015888282 | |
| Drug | arylsulfonamide analogue 16 | 1.47e-04 | 2 | 277 | 2 | CID015888284 | |
| Drug | Diphenyl Ether Sulfonamide 7 | 1.47e-04 | 2 | 277 | 2 | CID015888286 | |
| Drug | arylsulfonamide analogue 11 | 1.47e-04 | 2 | 277 | 2 | CID015888279 | |
| Drug | Diphenyl Ether Sulfonamide 12 | 1.47e-04 | 2 | 277 | 2 | CID010070710 | |
| Drug | AC1NR9V6 | 1.47e-04 | 2 | 277 | 2 | CID005287535 | |
| Drug | AAF-cmk | 1.47e-04 | 2 | 277 | 2 | CID006610326 | |
| Drug | AC1NRAF8 | 1.47e-04 | 2 | 277 | 2 | CID005287849 | |
| Drug | 1rww | 1.47e-04 | 2 | 277 | 2 | CID005289080 | |
| Drug | AC1L2I2N | 1.47e-04 | 2 | 277 | 2 | CID000021320 | |
| Drug | Biphenyl Sulfonamide 1 | 1.47e-04 | 2 | 277 | 2 | CID010449481 | |
| Drug | 1rwx | 1.47e-04 | 2 | 277 | 2 | CID005289610 | |
| Drug | aminoacetaldehyde | 1.47e-04 | 2 | 277 | 2 | CID000000363 | |
| Drug | PacMI | 1.47e-04 | 2 | 277 | 2 | CID000098723 | |
| Drug | Cyclo(lys-pro) | 1.47e-04 | 2 | 277 | 2 | CID000194922 | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; PC3; HT_HG-U133A | ESR1 GCNT2 TLN2 ARID3A APBB2 PHF7 ARHGAP35 MTERF4 PLXNC1 SNTG1 | 1.52e-04 | 196 | 277 | 10 | 3703_DN |
| Drug | Niflumic acid [4394-00-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.52e-04 | 196 | 277 | 10 | 7430_DN | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.52e-04 | 196 | 277 | 10 | 5669_DN | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; PC3; HT_HG-U133A | MAST2 UBE2D1 NBEAL2 FGFR4 RNF31 SHROOM2 UBE2D4 CEP131 ZMYM1 SKA1 | 1.52e-04 | 196 | 277 | 10 | 2099_DN |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; PC3; HT_HG-U133A | SCN11A CNKSR1 CDKAL1 SMG7 ALDH6A1 CASP1 TLN1 LY9 MYO15A AGRN | 1.52e-04 | 196 | 277 | 10 | 4238_DN |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; PC3; HT_HG-U133A | 1.52e-04 | 196 | 277 | 10 | 4582_UP | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 1.58e-04 | 197 | 277 | 10 | 6952_UP | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | MAST2 SMG7 AP2A2 TLN2 FGFR4 TMEM231 LRRC41 APBB2 CEP131 ATP2B4 | 1.58e-04 | 197 | 277 | 10 | 7011_DN |
| Drug | Glycopyrrolate [596-51-0]; Up 200; 10uM; HL60; HT_HG-U133A | 1.58e-04 | 197 | 277 | 10 | 2565_UP | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.58e-04 | 197 | 277 | 10 | 2307_DN | |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A | SCN11A HIVEP2 MAST2 MET AP2A2 RAD54B ARID3A ARHGAP35 ANKEF1 IRS2 | 1.58e-04 | 197 | 277 | 10 | 1508_DN |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; HL60; HG-U133A | 1.58e-04 | 197 | 277 | 10 | 1726_UP | |
| Drug | CP-319743 [172078-87-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.58e-04 | 197 | 277 | 10 | 7486_DN | |
| Drug | LY294002; Down 200; 0.1uM; MCF7; HG-U133A | 1.58e-04 | 197 | 277 | 10 | 424_DN | |
| Drug | Panthenol (D) [81-13-0]; Up 200; 19.4uM; MCF7; HT_HG-U133A | MAST2 INO80D CDKAL1 MET NLRX1 ARHGAP35 TLE1 CTSV ATP2B4 SENP7 | 1.58e-04 | 197 | 277 | 10 | 1680_UP |
| Drug | Moxonidine [75438-57-2]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.58e-04 | 197 | 277 | 10 | 4084_DN | |
| Disease | irritable bowel syndrome (implicated_via_orthology) | 7.73e-06 | 5 | 273 | 3 | DOID:9778 (implicated_via_orthology) | |
| Disease | cholelithiasis | 1.80e-05 | 88 | 273 | 7 | EFO_0004799 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 2.67e-05 | 7 | 273 | 3 | DOID:0060178 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IGGINCANRKPLSQE | 276 | P35503 | |
| IPLQGKSIVDNQCVL | 346 | A8MVM7 | |
| PRAKQVCNVEVGLQT | 181 | P51826 | |
| NPTGQVQSRKCIEDV | 271 | Q8TD30 | |
| QAQVDEGVPLKICLS | 101 | A8K979 | |
| CNDPGIIAENIRQVK | 161 | P16118 | |
| GCNVNIKNREGETPL | 501 | P53355 | |
| NPNNITCVLTKERFG | 201 | P41595 | |
| KEPQLSLLAAQCGLT | 96 | Q9HA82 | |
| PGKSSVAVNNCIRQL | 436 | Q92870 | |
| NIIDQCLQKPADVIG | 531 | Q9UJX5 | |
| LGENRDCNKQQPILA | 166 | Q8IW19 | |
| VKNQLCPVIEASFNG | 196 | Q8TDL5 | |
| DNTCKLNGSLPVAIT | 291 | P32302 | |
| ECQPAFELVGQKAIT | 546 | Q7Z408 | |
| EIQQPLCRKEGLCQI | 186 | A4D0V7 | |
| CLGIASAVPKFDQNL | 11 | O60911 | |
| KIPERGQCIINSNKD | 306 | P43652 | |
| CNSSPGVLKVLAQLG | 71 | Q96A70 | |
| VGFPNCSLLVQKLNL | 381 | Q2WEN9 | |
| KNIINLLGVCTQEGP | 531 | P22455 | |
| EREQLPDKCRNLSGQ | 271 | A8K2U0 | |
| ETIESVAQGIRKNCP | 126 | Q8IZF3 | |
| SNCPATKVFQGVLEL | 1126 | O00468 | |
| LSCVPVLIFANKQDL | 116 | P36405 | |
| ENDNTLCPGLRNAKV | 46 | Q16589 | |
| LCNDRVINSIPLAKQ | 321 | Q86XR8 | |
| KCAEALVPLLSNVNV | 121 | O15084 | |
| ECLRLLIGNAEPQNA | 631 | O15084 | |
| ELCPSGSIKQVALQI | 1941 | Q86UQ4 | |
| PDKEEQRSQINGVCL | 786 | O95342 | |
| VCLTFLEKGANPNAI | 166 | Q9NU02 | |
| LIKTRDICNQLQQPG | 406 | Q5JTW2 | |
| GETVELKCQVLLSNP | 36 | P01732 | |
| VIGAVQPNDISNKIC | 696 | Q96PN6 | |
| GLPQQIESVSDKCLL | 466 | A6NI56 | |
| VQNLCSRLKTSPVEG | 51 | P23634 | |
| GCRCEPLINKLENQL | 411 | Q9Y2G4 | |
| TKTTQIGCLLRLEPN | 896 | O94973 | |
| LPGIIKQGVNCLESQ | 431 | Q8N428 | |
| SCEKRIILTGTPIQN | 451 | Q9Y620 | |
| KINQAKPECGRQSLV | 576 | Q9H8V3 | |
| EDLCVQAAKASGILP | 51 | P52333 | |
| AKQCLLNGAPELAAD | 1046 | Q9ULG1 | |
| ICAEELGNNVKPAVT | 306 | Q9UJ83 | |
| ENKNLDLEPCTGFQR | 196 | O95453 | |
| ALGQCNELLEANPKA | 491 | Q9UGN5 | |
| LLKCQLQLLDSGAPE | 321 | Q9Y6F1 | |
| IGSINPNCNVLEVIK | 216 | Q15118 | |
| GVLQKCLESDELNVP | 196 | Q8NAB2 | |
| PQKQSFVLEVLSGCL | 41 | D6REC4 | |
| NIVNLLGACTKSGPI | 656 | P16234 | |
| GKTVTLQGNLDPCAL | 296 | P06132 | |
| PQAKERVCNLIDSGT | 361 | Q02252 | |
| NQSCDIALLPENRGK | 1716 | P23467 | |
| GSSPLQGLENCLKEI | 496 | A5PL33 | |
| PCNAELTILGRNTQI | 1981 | Q5T1H1 | |
| PGAGCRKLQQSSQLV | 241 | Q6ZVW7 | |
| ICFNIDSEPGKILNL | 716 | P19823 | |
| LICKAVLNPTNADIL | 651 | Q14643 | |
| RLTGLEPLATCENLQ | 86 | Q9BV99 | |
| CASQLEKGQLLSIPA | 81 | Q38SD2 | |
| PLKGQSDLDVLCNLL | 3086 | Q9UKN7 | |
| SGPKCQLRAQEQQSL | 276 | Q13201 | |
| EKRLVNCEPIGTQAS | 5521 | Q03001 | |
| CGQDFPLKTNREIVQ | 191 | Q8N0V5 | |
| KESPDGNNVACILTL | 306 | Q9H7Z6 | |
| SFEGIPVLECQNGKL | 1276 | Q9ULI0 | |
| PVLECQNGKLEVVSF | 1281 | Q9ULI0 | |
| TLCNRAEFKPGQENV | 441 | P54707 | |
| NCNSVLANKIFGIPL | 11 | Q9NYF5 | |
| ITGEKNLPCANVRQI | 406 | Q5T1V6 | |
| SICVDQNKPLFITAG | 246 | Q8TCX1 | |
| ISPLKICLAAENIVN | 3321 | Q5CZC0 | |
| NGEVQNLAVKCLGPL | 61 | Q86VP6 | |
| LVGCLEQALQDVPKE | 96 | Q9Y5L3 | |
| CIPNNQLSKPDALVR | 371 | Q8N5G2 | |
| KCPRIIQNGAIFQET | 196 | P29323 | |
| LCGQDLNKTSRQQIP | 41 | Q9H3H5 | |
| VGSICDLNLKIPEIN | 2111 | O75369 | |
| LQQADKLGCRQFVTP | 341 | P13797 | |
| KVILGENLTSNCPEV | 401 | O60486 | |
| IEAKPRNLNVSFQGC | 1551 | Q9Y4D7 | |
| PNLLLDRNQGKCVEG | 406 | P03372 | |
| PICKVTATDADLGQN | 166 | Q9NYQ8 | |
| LAKGCQLNFIENPVS | 66 | P18564 | |
| LPKLEFTLSQEVGCQ | 461 | Q96B70 | |
| SSQVVCRPEEGKILN | 1216 | Q02817 | |
| CENALQEGTLQRLPL | 76 | P14222 | |
| QLILEGNKISGICSP | 1111 | Q5S007 | |
| LNPKIQACSLSDGFI | 46 | P50748 | |
| QIKNFLGSCDPQVIL | 2091 | P50748 | |
| LGSCDPQVILKQLEE | 2096 | P50748 | |
| LLETCQNELKPGSVL | 531 | Q8N3J3 | |
| FVLKNTQCIPEGLES | 116 | P42857 | |
| LLEGNSNEDCKPLIL | 236 | P04150 | |
| GPKVASGENVTLLCQ | 331 | O75023 | |
| DLQNPDLVSLLLKCG | 226 | P25963 | |
| EKQIIEDNPLGSLCR | 836 | P16885 | |
| QLGCPIKNLDALENA | 641 | Q86UT6 | |
| KPGNLLVNSNCVLKI | 266 | Q9UBE8 | |
| GCRLAQQLFQKLSPE | 151 | Q3BBV0 | |
| EGCRLAQQLFQKLSP | 421 | Q3BBV0 | |
| PKAVELLGDIVQNCS | 141 | P31930 | |
| GLKTLNTVECFNPVG | 486 | Q9C0H6 | |
| QLVCKLLNIDGEPSS | 931 | Q8IVE3 | |
| PDVAKQLSNLALLCQ | 321 | Q9H0B6 | |
| NLLVQKDPLLSQACV | 1111 | Q5TIA1 | |
| GLQLRVSEDTCPLNV | 911 | Q86Y26 | |
| IGFVKLNCEQPSVTL | 226 | Q9Y4H2 | |
| TNFLKTEGQEQRLCP | 106 | Q99572 | |
| ELLCGLTQSENPALR | 471 | Q8IUR7 | |
| NLAPSLQLCQLGVKL | 286 | Q14674 | |
| LSRIEILAPQNGLCN | 1206 | B1AJZ9 | |
| KVNPCIELLVGVDIN | 66 | Q5T8I9 | |
| CPLILTQELGKANTT | 136 | Q9UHA7 | |
| QCQGELPDSTFVLLK | 1086 | Q8N6C5 | |
| LAEGLDIQLKSPVQC | 586 | Q8NB78 | |
| PQLSGACESKEIIIQ | 526 | P0C671 | |
| ALIDSVIPKGAQACQ | 56 | P29466 | |
| VISPIQNEAICAGKT | 76 | Q8NCX0 | |
| LTECQLKNPISGLLE | 496 | P55265 | |
| KLICQATGFSPRQIQ | 131 | P01871 | |
| ACAVVSLQQLPEKLN | 861 | O14981 | |
| PLNLQLGAKVSFVCD | 1726 | P17927 | |
| LTINLCNSVKGPGDL | 1371 | Q99715 | |
| VINLCGQDFPIKTNR | 201 | Q6ZNI0 | |
| PCLNGTLVQADRTNK | 306 | Q8IZS8 | |
| GQRPENIGQLEAKCL | 1796 | Q8TD26 | |
| NIGQLEAKCLASPSL | 1801 | Q8TD26 | |
| KNPLIEIISINTGCL | 201 | Q5VV42 | |
| AQLCGPAVNLSQIKD | 601 | Q6ZU35 | |
| PQTQLELCKSAVDAG | 496 | P09172 | |
| CNLILGAPDSQKLTT | 86 | P14784 | |
| AQNDTEPIVLEGKCL | 51 | Q8IUK8 | |
| QARSQVLLCGEVKNP | 46 | A4D0Y5 | |
| VCQPGNLNILVSKAS | 221 | Q9NZV1 | |
| NVFQSKGLRQEVICP | 636 | Q9Y2E4 | |
| LSPGDINLLAKDVCN | 1101 | Q8NFW1 | |
| LNVGCIPSKALLNNS | 81 | P09622 | |
| GCEVILVNVKTNLPS | 136 | Q8NFQ5 | |
| LSENICSGPERNTKL | 441 | Q9HBG7 | |
| DCATLLKNIGALPVD | 596 | Q6P0Q8 | |
| DRCSTILLQGKEQPL | 506 | P13637 | |
| LLQAASKEPECTGQL | 406 | Q53TQ3 | |
| SKEPECTGQLIQELR | 411 | Q53TQ3 | |
| FNATCLNNEVIPGLK | 396 | P05106 | |
| APVAQCQTLLGLIKD | 441 | Q92538 | |
| PVVQQLLDSGVCKVD | 681 | Q63ZY3 | |
| NIVKCASPLVLLEFQ | 91 | Q8IWA5 | |
| NAGQKVSLEGNPICL | 321 | P22680 | |
| AVCEDAKPGQLIQTI | 506 | Q9UJ99 | |
| PLRGQTSNTKLLGCQ | 341 | Q8WYP5 | |
| KLSNVVEFSVPLNGC | 311 | Q86UP6 | |
| INNLLGPLVEAKDCT | 1346 | Q49AJ0 | |
| LILLNQAIKTCGLPS | 2116 | A6NE01 | |
| ANGLINEIKPQSVCA | 31 | Q05048 | |
| ELNRSQEIGVKPLSC | 321 | Q16099 | |
| QEIGVKPLSCGSAQI | 326 | Q16099 | |
| QLCLSEVANGLRNPV | 206 | Q6UWX4 | |
| NGEVQNLAVKCLGPL | 61 | O75155 | |
| SEVIQPNLAKACQLL | 356 | Q5T7M9 | |
| LSGKCVVALATDPNI | 231 | Q96LJ7 | |
| EKCPQLVLVNGEDLT | 111 | Q9UNA4 | |
| APSLNNIIKAATCEG | 206 | Q9UPN4 | |
| AQVGKLPCLEISQSV | 706 | P28340 | |
| VKQLLLFSETEGNPC | 511 | Q96RY7 | |
| LQIVCKGLEDPSQVV | 396 | Q8TEX9 | |
| NLEALLIQIGPKECV | 186 | P43246 | |
| PQQKLVIVESCQRLG | 706 | P20648 | |
| ALIDSVIPKGAQACQ | 56 | Q5EG05 | |
| DTPGITKENCILNLL | 496 | Q8NC60 | |
| LNLSGRNLSEVPQCV | 41 | Q9H9A6 | |
| CITSLPEKVGQLSQL | 786 | Q7L1W4 | |
| TLQKAPCEQNLGLVC | 521 | Q3ZCN5 | |
| QQDRPKSQDCLGLVA | 516 | A6NNC1 | |
| DAQQDRPKSQDCLGL | 786 | A6NNC1 | |
| AVLCTVPNDLLKLNS | 891 | P08581 | |
| NSPVLKALGSACIEI | 3871 | O75445 | |
| CQKLEPLRQSLNLSE | 146 | Q9BQF6 | |
| LNPSLAQEAAKLCGD | 671 | Q9UGT4 | |
| QVLFPLKNETLVGDC | 246 | Q9BQS2 | |
| RPDKISGADINSICQ | 366 | P43686 | |
| LRNCGQEPTLKTVLN | 26 | Q96BD8 | |
| PSACQGQRLFEKLLQ | 161 | Q8N7P1 | |
| RPLTNCSIINSGKID | 186 | P45877 | |
| ASIGELTLIPQCSQK | 396 | Q9H4L7 | |
| LKQEDGSLCLVQFPS | 86 | P09132 | |
| QAKDEQGPIRCNTTV | 436 | Q96KG9 | |
| NDCAQKILPVLCGLT | 501 | Q96KG9 | |
| GNICLQLAPESKFQV | 136 | Q7LBE3 | |
| VGVNTNLKDLCPLLS | 301 | A6NFQ2 | |
| QLDISSNCIKPDGLL | 736 | Q15345 | |
| GCRLAQQLVQKLSPE | 151 | Q5TAG4 | |
| CLILSSKLPQRGQSN | 61 | Q9BWX1 | |
| KVACLDPLFLGNQAT | 486 | Q9NSN8 | |
| GTPQSLGLNLVKIQC | 221 | Q8TC59 | |
| QEKLEIRLCPDGSGQ | 591 | Q9BVG8 | |
| RNLVQCLLEKQGTPV | 71 | Q7Z6M4 | |
| CLLEKQGTPVVQGSL | 76 | Q7Z6M4 | |
| GIVPLAKVDCTANTN | 76 | P30101 | |
| LKALSEGCPLLEQLN | 161 | Q96IG2 | |
| GNSINLCTAKEIADP | 341 | Q5VWT5 | |
| QRGCSQLLLQVPDLA | 171 | Q5JWF2 | |
| CLQLTNEKVGDVVLP | 2236 | Q6ZNJ1 | |
| NAVQCIRNLNPGLKT | 291 | Q9UPR0 | |
| RNLSNNCDTGEKPVV | 531 | Q92540 | |
| NCKERGFNNISELLP | 391 | O94933 | |
| DNCLQSVLGQRVDLP | 796 | Q5VSL9 | |
| SGKQSILSVRLEQCP | 136 | Q9BPZ7 | |
| EQLKCLLDSLQPERG | 1601 | Q13796 | |
| LTPAGLAIKNGQLEC | 386 | Q9Y6H5 | |
| LSAQVQLGQVEIKCP | 291 | Q8TC41 | |
| NTKVPELCLGINELS | 976 | Q8IX21 | |
| PCLTQLLTAAKPEQA | 526 | Q9NP71 | |
| GQQIASKLQCVFLDP | 721 | Q9NRY4 | |
| SVNIQRNPKEGLLCA | 741 | Q9NRH2 | |
| RQNSEGSASKVPCIL | 366 | Q9UJM3 | |
| VSLNVKGPCVSENEL | 426 | Q15437 | |
| ADLENLSKLTGVCPQ | 551 | O94911 | |
| LQVILNKDTGISCDP | 211 | Q9Y478 | |
| SCLKSAPIVGDQEQA | 571 | O75969 | |
| EQEADRINLQKCLGP | 266 | P35612 | |
| ASVGLEVLAEKCPNL | 76 | O95626 | |
| ECEKRGLSNPNELQA | 326 | Q99856 | |
| GQQLVTKLVTAPVAC | 706 | O15516 | |
| SITPLSELVGLCKNN | 306 | Q9BPX3 | |
| LQSDCVVQEGKSPRQ | 26 | Q86WW8 | |
| KNLLQLCPQSLEALA | 36 | Q969H4 | |
| VDSRDAGICLQPLQQ | 386 | Q96EP0 | |
| GSELQLPFQACLKVE | 1886 | Q6P2Q9 | |
| NLVQLEGCCTEKLPL | 176 | Q6J9G0 | |
| VEGFSKVQQLCSLIP | 1291 | O75443 | |
| LNLSVKDPCNTQAPR | 551 | Q32MQ0 | |
| RKPNVGCQQDSEELL | 341 | A0AVT1 | |
| PNINSNGSICLDILR | 76 | P62837 | |
| IPETQIVTCNGKRLE | 126 | O15205 | |
| GNKSPVSQLDCLNRD | 516 | Q04724 | |
| SENRPVCKAIIQGKQ | 6 | P63127 | |
| KSPLALLAQTCSQIG | 86 | Q9H7S9 | |
| CQLPALGLLQDIKDA | 236 | Q96F44 | |
| KDCPSGRLNLEEFQQ | 36 | P62760 | |
| PSKGVSAQCLFDLLQ | 2291 | Q8N2C7 | |
| SENRPVCKAIIQGKQ | 6 | P63129 | |
| GQTPVQERLSCLAKN | 116 | O95497 | |
| LCQQDLGSRKLEDAP | 31 | H3BPM6 | |
| LKQEPQRQHLACLGT | 476 | Q5VZE5 | |
| VKPFTEAQLLCTQAG | 271 | P35247 | |
| RLQTPQKDCELAGSV | 91 | Q9UQP3 | |
| IANECQANFISIKGP | 531 | P55072 | |
| ELELLVSQQSPCGRA | 176 | O43557 | |
| QAPGQKECDNALREL | 1356 | Q9Y490 | |
| KEISLPILCNASNGS | 376 | Q5TCZ1 | |
| SENRPVCKAIIQGKQ | 6 | P63121 | |
| KQLNPINLTERGCVT | 176 | O00442 | |
| SENRPVCKAIIQGKQ | 6 | P63131 | |
| LKFNQESGALIPLCL | 371 | Q9UMX1 | |
| LLNGFQAIKLNPSIC | 141 | Q9GZP7 | |
| PTNDLLLKTVENGLC | 1571 | O60281 | |
| NLKDGVNACILPLLQ | 126 | Q9Y5S1 | |
| LFNQIPELQGKLCSR | 506 | Q5GFL6 | |
| SENRPVCKAIIQGKQ | 6 | Q9Y6I0 | |
| PNINSNGSICLDILR | 76 | P61077 | |
| SENRPVCKAIIQGKQ | 6 | P63125 | |
| KQRTVLVVCGPEQNG | 116 | A6XGL0 | |
| DLIAKILASCPQQSL | 351 | Q9C0B7 | |
| PNLLRSKEIEATGCN | 176 | Q2M1Z3 | |
| SENRPVCKAIIQGKQ | 6 | P10265 | |
| CGPENSVLAQDKLLL | 296 | Q00722 | |
| CVSQLGQRAEPKATE | 51 | Q96JL9 | |
| PTKECLQSEAVLQRG | 811 | Q6PKC3 | |
| SPLALLAQTCSQIGK | 111 | Q96F45 | |
| SRNCVIKELAPQQEG | 96 | Q09FC8 | |
| LRLQQKQPLSCGGLD | 176 | Q9H6L2 | |
| SSPVCQEQLIEAGKL | 731 | Q9Y4G6 | |
| LVQKAGALQVCPTDS | 1931 | Q9Y4G6 | |
| LNNIRCFKIDQPSTG | 1151 | O60346 | |
| PLNKCQGLVFDIVTS | 1351 | Q9UI33 | |
| KSCISQTPGINLDLG | 41 | Q9HD64 | |
| KQCLPLRGNDQSVSS | 566 | Q5SVZ6 | |
| PNINSNGSICLDILR | 76 | Q9Y2X8 | |
| SENRPVCKAIIQGKQ | 6 | P63122 | |
| CGSITLALGNAQKLP | 11 | Q7Z7G0 | |
| ILGQNSPAIVICKVD | 1356 | P31629 | |
| QLTGDPAKGNCSLVI | 91 | Q96LC7 | |
| PCQRAAETVLKQQGV | 181 | P56192 | |
| SENRPVCKAIIQGKQ | 6 | P63119 | |
| ALILQLFSQIGPCKN | 21 | P31483 | |
| CEKRENLLPFVGLNN | 71 | O94782 | |
| VKEQLPCAGLNCQAL | 371 | Q9H808 | |
| PNINSNGSICLDILR | 76 | P51668 | |
| SENRPVCKAIIQGKQ | 6 | P63124 | |
| VATGKSCLINELENP | 1611 | Q9BYP7 | |
| SENRPVCKAIIQGKQ | 6 | P63120 | |
| ILDCKNIFGEPVNLT | 196 | Q9C099 | |
| PNTLNCSLDVVLKEG | 241 | B1AL88 | |
| CEQGINPEALSSVIK | 51 | Q08AG7 | |
| AEFDNPNIVKLLGVC | 631 | O15146 | |
| ASLPAELINQIGNRC | 341 | Q96RE7 | |
| VQFLNCVLEGDPVKT | 1556 | Q86UW6 | |
| LPATQCTKFINQLLG | 376 | Q14CX7 | |
| PDLLTFVQNLCKGLS | 156 | Q96NK8 |